Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC17A6 mRNA | affects expression | 16483693
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC17A6 mRNA | affects cotreatment|increases expression | 18164116
|
D003024 |
Clozapine |
Clozapine results in increased expression of SLC17A6 mRNA | increases expression | 18155072 17266109
|
D003024 |
Clozapine |
Clozapine results in increased expression of SLC17A6 protein | increases expression | 18155072
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC17A6 mRNA | affects cotreatment|increases expression | 18164116
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of SLC17A6 mRNA | increases expression | 18155072
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of SLC17A6 protein | increases expression | 18155072
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of SLC17A6 mRNA | decreases expression | 16807920
|
D008094 |
Lithium |
Lithium results in increased expression of SLC17A6 mRNA | increases expression | 18155072
|
D008094 |
Lithium |
Lithium results in increased expression of SLC17A6 protein | increases expression | 18155072
|
D010622 |
Phencyclidine |
Phencyclidine results in increased expression of SLC17A6 mRNA | increases expression | 17266109
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC17A6 mRNA | affects binding|increases activity|increases expression | 19710929
|
C025299 |
polyphenols |
polyphenols results in decreased expression of SLC17A6 mRNA | decreases expression | 16293270
|
D018967 |
Risperidone |
Risperidone results in increased expression of SLC17A6 mRNA | increases expression | 18155072
|
D018967 |
Risperidone |
Risperidone results in increased expression of SLC17A6 protein | increases expression | 18155072
|
C009250 |
sevoflurane |
sevoflurane affects the expression of SLC17A6 mRNA | affects expression | 15967596
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
7.08 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.08 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.61 | 16434500 19061943 17620307 19052882 17162532 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.61 | 16434500 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.19 | 12649775 14617031 16160616 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
3.48 | 19621015 |
MESH:D020817 |
Asperger Syndrome |
|
Risperidone |
5.61 | 16401163 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Risperidone |
4.86 | 18349709 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.87 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
Risperidone |
2.87 | 19232924 18349709 16601648 16239862 17019624 19368416 16730335 19013209 18080171 16379507 17929164 18278980 19154706 18026891 15543515 16948927 15994720 17069546 15930063 18775368 15492353 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
8.32 | 20046352 20338123 17594078 19153942 |
MESH:D001714 |
Bipolar Disorder |
|
Risperidone |
8.32 | 18278980 19154706 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.26 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.22 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.86 | 18971187 20084675 18056438 20935162 19919837 17138121 18788625 16698587 18393292 3084413 16681979 19107877 20432363 19383236 18665156 18210153 20727157 17173139 18691550 19701751 16878318 16540662 16502159 11831363 16569478 20007298 16328049 19171122 10672840 16830150 10737359 17162532 20514400 18785209 19052882 18494052 17761372 19539802 19208518 18506893 16935385 16288022 19418558 18978308 20214788 16807293 17055752 19822196 17978847 20512989 20524982 17428255 20101231 19519916 21159647 16779866 3581430 19335982 19394651 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.06 | 1977408 15215559 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.93 | 2727394 7505956 17174075 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.78 | 19052882 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.91 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.10 | 17123785 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.69 | 16293270 |
MESH:D007644 |
Darier Disease |
|
Lithium |
6.06 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
11.85 | 20210726 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Risperidone |
11.85 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
10.92 | 11575062 |
MESH:D003704 |
Dementia |
|
Risperidone |
10.92 | 11575062 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.88 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.78 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.78 | 20387270 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
15.04 | 15331141 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Risperidone |
15.04 | 16379507 |
MESH:D053207 |
Diurnal Enuresis |
|
Risperidone |
6.85 | 17822346 |
MESH:D004314 |
Down Syndrome |
|
Risperidone |
5.13 | 18349709 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
4.27 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
4.27 | 19370779 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.26 | 16402076 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.59 | 12083418 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.29 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
8.05 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.05 | 19236843 20131406 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
4.27 | 19638421 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.60 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.13 | 19176532 16221962 19772884 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
10.00 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Risperidone |
10.00 | 18278980 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.06 | 16046005 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
5.52 | 18785209 |
MESH:D007249 |
Inflammation |
|
polyphenols |
5.52 | 16366677 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007859 |
Learning Disorders |
|
sevoflurane |
4.91 | 19212262 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.04 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.88 | 18665156 19638242 18522880 18407596 20032147 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.34 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.41 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
4.41 | 16698588 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
7.70 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
7.70 | 21278145 19254457 20583210 15175105 19073162 19294768 20137499 18754104 18644402 18977376 19426721 20101389 19256749 19642983 12112319 20452335 19833225 18648771 19427195 2422723 19255062 19090486 19499222 20118626 20434301 19551842 19638242 20501860 21167192 19812893 19996281 18978307 16942905 2862719 19850985 21071580 9163691 21047994 15885732 12771043 20492335 10737359 19690152 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.70 | 16377806 15890375 20007298 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
6.35 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.35 | 18079962 17942915 16267830 19519916 2563599 18093689 19539802 18253720 17174075 17854601 9362446 19126423 19009564 21159647 19004024 18775883 18544905 18308698 3124819 16842330 18282651 18164116 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 20512841 20970405 21163286 6695378 |
MESH:D008569 |
Memory Disorders |
|
sevoflurane |
4.87 | 19212262 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
14.39 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
14.39 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Risperidone |
14.39 | 16856516 16596465 |
MESH:D008607 |
Mental Retardation |
|
Risperidone |
4.14 | 18349709 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
10.50 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
Risperidone |
10.50 | 19142101 |
MESH:D019964 |
Mood Disorders |
|
Risperidone |
5.97 | 17019624 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
6.21 | 16288908 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.21 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.60 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.99 | 17405874 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.43 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.29 | 20387270 |
MESH:D053206 |
Nocturnal Enuresis |
|
Risperidone |
6.50 | 17822346 |
MESH:D009765 |
Obesity |
|
Clozapine |
4.78 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.78 | 20558911 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.45 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.65 | 2563599 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.09 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.42 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.42 | 11575062 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
6.00 | 18855531 11151749 20452607 20168265 11763009 20107430 19369910 20521320 17123785 17667964 20521326 20580759 18806925 16141801 17726453 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
6.00 | 20107430 1830565 18513383 19369910 |
MESH:D012559 |
Schizophrenia |
|
Risperidone |
6.00 | 20107430 19154706 18278980 |
MESH:D012640 |
Seizures |
|
Lithium |
4.05 | 19660546 |
MESH:D012893 |
Sleep Disorders |
|
Risperidone |
5.66 | 18278980 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
5.96 | 19430551 19951488 19570321 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
11.41 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Risperidone |
11.41 | 20210726 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.43 | 17997062 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.07 | 7505956 |
MESH:D005879 |
Tourette Syndrome |
|
Risperidone |
6.08 | 19154706 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
10.71 | 16141801 16402076 20107430 20521320 17502770 20564506 |
MESH:D015430 |
Weight Gain |
|
Risperidone |
10.71 | 20564506 16379507 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.23 | 17933447 |